Stemline Therapeutics Inc's ability to collect accounts receivable sequentially worsen to 3.21, indicating more challenging environment then in the fourth quarter 2019, but still, it is a far cry from any concerns. Stemline Therapeutics Inc's Accounts Receivable average collection period in the Mar 31 2020 quarter, has increased to 114 days, from 111 days, in the Dec 31 2019 quarter.

If we take a look into Healthcare sector 406 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2991, from overall ranking in the fourth quarter 2019 at 3343.

What is Receivable Turnover Ratio?
What is Stemline Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

STML Receivables Turnover Ratio	(Mar 31 2020) I. Quarter	(Dec 31 2019) IV. Quarter	(Sep 30 2019) III. Quarter	(Jun 30 2019) II. Quarter	(Mar 31 2019) I. Quarter
Y / Y Receivable Change	111.43 %	-	-	-	-
Y / Y Revenue Change	75.74 %	-	-	2501.34 %	-
Receivable Turnover Ratio (TTM)	3.21	3.3	3.37	3.49	3.95
STML's Total Ranking	# 2991	# 3343	# 3210	# 0	# 2731
Accounts Receivable average collection period days	114	111	108	105	92
Seq. Receivable Change	-21.43 %	-8.73 %	9.76 %	168.61 %	-
Seq. Revenue Change	-24.99 %	-11.28 %	2.51 %	157.63 %	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 129
Healthcare Sector	# 407
Overall Market	# 2991

Receivable Turnover Ratio Statistics
High	Average	Low
0.28	0.06	0
(Mar 31 2020)		(Sep 30 2014)

STML Company Profile • Back to STML Efficiency Comparisons • Compare STML Receivables Turnover Ratio to its Competitors

Financial Statements
Stemline Therapeutics Inc's Accounts Receivable	$ 12 Millions	Visit STML's Balance sheet
Stemline Therapeutics Inc's Sales TTM	$ 47 Millions	Visit STML's Income Statement
Sources of STML's Revenues		Visit STML's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
STML's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
STML's Growth Rates	STML's Roa	STML's Inventory Turnover Ratio	STML's Dividend Comparisons
STML's Profitability Ratios	STML's Roi	STML's Asset Turnover Ratio	STML's Dividend Growth
STML's Valuation Ratios	STML's Roe	STML's Financial Strength Ratios	STML's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2020, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2020	Receivable at quarter ending Mar 31 2020
Travere Therapeutics Inc	10.74	$ 183.537 Millions	$ 17.091 Millions
Orthofix Medical Inc	10.73	$ 455.666 Millions	$ 42.465 Millions
Rigel Pharmaceuticals Inc	10.71	$ 102.425 Millions	$ 9.564 Millions
La Jolla Pharmaceutical Company	10.69	$ 26.250 Millions	$ 2.456 Millions
Immucell Corporation	10.67	$ 14.223 Millions	$ 1.333 Millions
Scienture Holdings Inc	10.51	$ 8.127 Millions	$ 0.773 Millions
National Healthcare Corp	10.49	$ 1,004.222 Millions	$ 95.718 Millions
Teladoc Health Inc	10.48	$ 605.533 Millions	$ 57.779 Millions
Acadia Pharmaceuticals Inc	10.46	$ 366.185 Millions	$ 35.001 Millions
Pacira Biosciences inc	10.23	$ 435.397 Millions	$ 42.560 Millions
Zynex inc	10.21	$ 51.504 Millions	$ 5.044 Millions
Exact Sciences Corporation	10.19	$ 1,062.071 Millions	$ 104.204 Millions
Inovio Pharmaceuticals Inc	10.02	$ 5.632 Millions	$ 0.562 Millions
Dmk Pharmaceuticals Corporation	10.01	$ 21.871 Millions	$ 2.185 Millions
Adamas Pharmaceuticals Inc	9.79	$ 57.453 Millions	$ 5.866 Millions
Alpha Pro Tech Ltd	9.76	$ 52.515 Millions	$ 5.382 Millions
Utah Medical Products Inc	9.68	$ 47.074 Millions	$ 4.864 Millions
Novavax inc	9.63	$ 18.057 Millions	$ 1.875 Millions
Allied Healthcare Products inc	9.62	$ 31.073 Millions	$ 3.230 Millions
Ardelyx inc	9.56	$ 6.494 Millions	$ 0.679 Millions
Insmed Inc	9.56	$ 151.425 Millions	$ 15.843 Millions
Karyopharm Therapeutics Inc	9.39	$ 58.876 Millions	$ 6.268 Millions
Silk Road Medical Inc	9.39	$ 69.521 Millions	$ 7.405 Millions
Bausch Health Companies Inc	9.36	$ 8,597.000 Millions	$ 918.000 Millions
Acorda Therapeutics Inc	9.33	$ 176.370 Millions	$ 18.904 Millions
Chimerix Inc	9.28	$ 11.382 Millions	$ 1.227 Millions
Irhythm Holdings Inc	9.26	$ 230.873 Millions	$ 24.944 Millions
Abiomed Inc	9.19	$ 840.883 Millions	$ 91.542 Millions
Kyntra Bio Inc	9.13	$ 257.115 Millions	$ 28.168 Millions
Portola Pharmaceuticals inc	9.10	$ 120.860 Millions	$ 13.287 Millions

Date modified: 2026-10-07T00:41:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.